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There is confusion about the role that IFN-α plays in the pathogenesis of pulmonary arterial
hypertension (PAH) with different investigators reporting a causative or a protective role.
There is now clear evidence in PAH pathogenesis for the involvement of BMP4 and BMP9
signaling, and its disruption by mutations in BMPR2. In the present study, we investigated
MxA, an IFN-α-inducible cytoplasmic dynamin-family GTPase for effects on BMP4/9 signaling, including in the presence of PAH-disease-associated mutants of BMPR2. In human
pulmonary arterial endothelial cells (HPAECs), IFN-α-induced endogenous as well as exogenously expressed MxA was associated with endosomes that aligned alongside microtubules and tubules of the endoplasmic reticulum (ER). Moreover, IFN-α and MxA stimulated
basal and BMP4/9 signaling to a Smad1/5/8-responsive pBRE-Luc reporter. In HEK293T
cells, immunoelectron microscopy confirmed the association of MxA with endosomes, and
immunofluorescence methods showed these to be positive for early endosome markers
(early endosomal antigen 1, clathrin light chain and Rab5) and RSmad1/5/8. Functionally,
using different genetic and inhibitor approaches, we observed that clathrin-mediated endocytosis enhanced and caveolin-mediated endocytosis inhibited the transcriptional response
to BMP4 and BMP9. MxA produced a further 3-4-fold enhancement of the BMP-induced
response in a clathrin-endocytosis dependent manner. The microtubule inhibitor nocodazole and stabilizer paclitaxel respectively attenuated and enhanced the effect of MxA, implicating microtubule integrity in this process. MxA enhanced BMP-induced signaling in the
presence of wild-type BMPR2, and partially rescued signaling from some PAH-diseaseassociated BMPR2 mutants. Taken together, the data identify MxA as a novel stimulator of
BMP4 and BMP9 transcriptional signaling, and suggest it to be a candidate IFN-α-inducible
mechanism that might have a protective role against development of PAH and other vascular diseases.
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Introduction
Idiopathic pulmonary arterial hypertension (PAH) is a devastating disease with high morbidity
and mortality affecting young women 2-4-fold more frequently compared to men (median age
at onset in women is in the third decade; in men it is in the fourth decade) [1,2,3]. In this disease, there is a decrease in the lumen of precapillary pulmonary arterial segments due to vascular remodeling characterized by enlarged tunica media leading to the typical onion-skin or
plexiform lesions [1,2,3]. Hereditary PAH comprises kindreds with haploinsufficiency of or
autosomally dominant mutations in the bone morphogenetic receptor protein 2 (BMPR2) gene
[1,2,3]. A consequence of these mutations in BMPR2 is a decrease in transcriptionally productive signaling by the bone morphogenetic proteins (BMPs), allowing greater proliferation of
vascular cells. BMP signaling typically inhibits vascular proliferation; indeed studies in the last
decade have identified BMP4 and BMP9 to be of special relevance in maintaining vascular
endothelial and smooth muscle cells in a state of quiescence [4,5]. Thus, disruption of BMP4
and/or BMP9 signaling is thought to be a contributory factor in reversing this quiescent state
culminating in vascular cell proliferation and PAH. Additionally, acquired PAH (without
underlying mutations in BMPR2) has resulted from the ingestion of anorexigenic drugs and
plant products (e.g. rape seed oil), and parasitic infections (e.g. schistosomiasis) with pathogenesis thought to include underlying inflammation in pulmonary arterial segments accompanied by local cytokine production [3,6]. Indeed, an unusual example of acquired PAH occurs
in patients, mainly women, who have been administered Type I interferons (IFNs). A small
subset (approximately 0.5%) of patients, mainly women, administered IFN-α or β for chronic
myelogenous leukemia, multiple sclerosis or other conditions developed PAH, which could be
reversed in some but not all patients by cessation of the IFN therapy [7,8,9].
An understanding of the underlying mechanisms of this pathogenesis has been confusing.
George et al [10] reported that male IFNAR1-/- mice were protected from development of
PAH upon exposure to chronic hypoxia. Specifically, George et al [10] concluded that Type I
IFNs mediate PAH. In contrast, Bauer et al [11] reported that IFN-α2b administration inhibited development of PAH in male rats exposed to the inhibitor SU5416 and chronic hypoxia
or in male mice exposed to chronic hypoxia alone. Moreover, IFNAR1-/- mice developed PAH
equivalent to that observed in wt mice after chronic hypoxia, and were not protected by IFN-α
administration. Thus, Bauer et al [11] provided data showing that IFN-α was protective in
hypoxic PAH in male mice. Bauer and colleagues noted the contrast between their data, especially in hypoxic IFNAR1-/- male mice, and those of George et al [10], and expressed puzzlement about the underlying mechanisms that might lead to contrasting outcomes. In
attempting to understand these contrasting observations, we focused on a protein long-known
to be specifically induced by Type I IFNs–the myxovirus resistance protein A (MxA)–and
whether this protein might affect signaling in response to BMP4 and BMP9 [12,13,14].
MxA and related family members (MxA and MxB in humans; Mx1 and Mx2 in mice) are
typically upregulated 10-100-fold by Type I (IFN-α species and IFN-β) and Type III (IFN-λ
species) IFNs but not by Type II (IFN-γ) IFN [12,13,14]. The 70-kDa human MxA protein is a
cytoplasmic dynamin-family atlastin-like GTPase and is a mediator of the broad-spectrum
antiviral activity of IFNs [12,13,14]. At the biochemical level, MxA molecules oligomerise into
dimers and multimeric rings, and bind intracellular membranes causing membrane bending
and tubulation [15,16]. In intact cells, MxA has been reported to increase caveolar endocytosis
and enhance IL-6/STAT3 signaling [17]. In as much as it is well established that signaling initiated at the plasma membrane by several cytokines and growth factors, including transforming
growth factor β (TGF-β), BMP2, and IL-6, transits the cytoplasm along membrane-associated
endocytic pathways to generate a transcriptional response [17,18,19], we investigated the
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possibility that the IFN-inducible membrane-bioactive MxA might affect BMP4 and BMP9
signaling, and thus participate in IFN-mediated alterations in PAH pathogenesis.
In the present study we have investigated the organellar association of IFN-α-induced
endogenous MxA in human pulmonary arterial endothelial cells (HPAECs), as well as that of
exogenously expressed MxA in HPAECs and HEK293T cells. With the discovery that MxA in
such cells was associated with early endosomes (the MxA-endosomes) which were, in turn,
associated with microtubules and ER tubules as scaffolds [20,21,22,23,24], we investigated
whether IFN-α and MxA affected productive transcriptional signaling by BMP4 or BMP9.
This provided us with a model system to test the functional consequences of endosome trafficking in association with microtubules and ER tubules suggested by the scaffolding hypothesis of Voeltz and colleagues [24]. We also investigated whether MxA might rescue the
inhibitory effects of PAH-disease causing mutants of BMPR2 on BMP4/9 signaling. Overall,
the discovery of MxA endosomes and their contribution towards stimulating BMP4/9 signaling identifies a novel candidate mechanism by which Type I IFNs could be protective in the
pathogenesis of vascular disease.

Results
MxA-endosomes in HPAECs lie alongside ER tubules and microtubules
In contrast to prior reports that inferred that MxA colocalized with subcompartments of the
endoplasmic reticulum (ER) [14,15,25,26,27,28], we found that in HPAECs MxA associated
with endosomes which were distinct from ER tubules, and which lay alongside microtubules
and ER tubules (Figs 1 and 2). We first investigated endogenously expressed MxA in primary
HPAECs induced with IFN-α. Fig 1A illustrates a Western blot analysis showing that unstimulated HPAECs expressed very little MxA, and that IFN-α treatment markedly enhanced MxA
expression. The single-label immunofluorescence analyses shown in Fig 1B show that this
MxA was largely cytoplasmic. A double-label immunofluorescence analysis to evaluate the
association of MxA with the standard RTN4-based ER summarized in Fig 1C showed (a) that
the endogenously-expressed cytoplasmic MxA associated with endosomes, (b) that the MxA
endosomes were clearly distinct from the ER tubules, and, (c) a subset of the MxA endosomes
were aligned with and lay alongside ER tubules (see high-magnification of the boxed inset in
the merged panel in Fig 1C lower right).
Fig 2 summarizes characterization of exogenously expressed MxA in HPAECs resulting
from transient transfection with a constitutive expression vector for HA-tagged MxA. Fig 2A
shows the dramatic alignment of MxA-endosomes alongside microtubules, and Fig 2B the
presence of variably-sized MxA endosomes at the cell periphery, some of which aligned alongside ER tubules.

MxA associates with early endosomes in HEK293T cells
Because of the well-known difficulty with carrying out replicable transient transfections of primary HPAEC cultures with significant frequency of transfected cells expressing an exogenous
protein, we investigated exogenously expressed MxA in the more readily transfected
HEK293T cells as has been used earlier in the MxA field [28,29]. An additional advantage of
293T cells has included a low-level of endogenous MxA expression (if at all) even after IFN-α
treatment. Thus, these cells have been used by prior investigators in structure-function studies
of mutants of MxA [28,29]. Fig 3A shows that exogenously expressed MxA in HEK293T cells
was largely cytoplasmic and associated with endosomes. Fig 3B and 3C show that the MxA
endosomes were distinct from RTN4-positive ER tubules, however, Fig 3C again shows that
some of the MxA endosomes lay alongside ER tubules. The immuno-EM data summarized in
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Fig 1. Endogenous MxA in HPAECs localizes to endosomes that lie alongside ER tubules. HPAEC
cultures were exposed to IFN-α for 16 hr at the indicated concentrations. Panel A illustrates Western blots for
MxA and β-actin of whole cell extracts (80 μg protein/lane); quantitation of the blot shown in terms of MxA
induction normalized to β-actin is shown in the graph on the right. Panel B shows single-label
immunofluorescence for MxA. Scale bar = 10 μm. Panel C shows double-label immunofluorescence for MxA and
RTN4 of the periphery of cell in an IFN-treated culture (1000 IU/ml). The boxed inset in the merged panel is
illustrated at higher magnification in the lower right. Scale bars = 10 μm. In Panel C, Pearson’s R (with Costes’
automatic thresholding) was 0.143 comparing RTN4 and MxA images.
doi:10.1371/journal.pone.0166382.g001
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Fig 2. MxA-positive endosomes lie alongside microtubules and the RTN4-positive endoplasmic
reticulum in HPAECs. Double-label immunofluorescence imaging was carried out on MxA-vector
transfected HPAECs for MxA and RTN4 using a 40x water-immersion (Panel A) or 100x oil-immersion
objective (Panel B). Panel A: Double-label analysis for MxA and β-tubulin (scale bar = 10 μm). The area in the
white rectangle is also shown at higher magnification (scale bar = 5 μm).Panel B: Double-label analysis for
MxA and RTN4 (a marker of the standard ER) (scale bar = 10 μm). The area in the white rectangle is also
shown at higher magnification (scale bar = 5 μm). In Panel A, Pearson’s R (with Costes’ automatic
thresholding) was 0.142 comparing tubulin and MxA images. In Panel B, Pearson’s R (with Costes’ automatic
thresholding) was 0.23 comparing RTN4 and MxA images.
doi:10.1371/journal.pone.0166382.g002
PLOS ONE | DOI:10.1371/journal.pone.0166382 November 22, 2016
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Fig 3. MxA-positive endosomes lie alongside the RTN4-positive endoplasmic reticulum in HEK293T
cells. Single and double-label immunofluorescence imaging was carried out on MxA-vector transfected
HEK293T cells using for MxA and for MxA and RTN4 using an 100x oil-immersion objective and z-stack
image capture and deconvolution. Panel A: Images represent the combined deconvolved z-stack images of
MxA of two individual MxA-overexpressing HEK 293T cells. Images show MxA-positive endosomes in the
cytoplasm. Panel B illustrate merged MxA and RTN4 deconvolved z-stack images showing MxA-endosomes
alongside RTN4-positive endoplasmic reticulum (but distinct from the ER). Panel C shows MxA-endosomes
alongside RTN4-endosplasmic reticulum in from a second cell. Scale bars = 10 μm on Panel A, and 5 μm
each in Panels B and C. In Panel B, Pearson’s R (with Costes’ automatic thresholding) was 0.064 comparing
RTN4 and MxA images.
doi:10.1371/journal.pone.0166382.g003

Fig 4 confirm the association of MxA with endosomes both at the level of the plasma membrane vicinity and throughout the cytoplasm. The high-magnification inset (Fig 4C) of the
boxed region in Fig 4B shows the association of MxA with endosomes at the level of the plasma
membrane vicinity in MxA-expressing cells.
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Fig 4. Evidence for MxA endosomes by immunoelectron microscopy. HEK293T cells were transfected with
either pcDNA (Panel A) or the pMxA-HA vector (Panel B). One day later the respective cultures were processed for
immuno-EM using anti-MxA rabbit pAb and Protein A-15 nm colloidal gold. Arrows point to the intercellular space
between adjacent cells. The boxed inset in Panel B is shown at higher magnification in panel C. Scale bars = 1 μm.
doi:10.1371/journal.pone.0166382.g004
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A characterization of MxA endosomes in 293T cells using double-label immunofluorescence analyses (Fig 5) showed that these were positive for early endosome markers [early
endosome antigen 1 (EEA1), clathrin-light chain (CLT-LC) and Rab 5] and also for the
transcription mediators RSmad1/5/8. In contrast these endosomes were negative for
caveolin-1 and lysosome membrane protein 2 (LAMP2). Thus MxA endosomes included
protein markers associated with early endosomes in the clathrin-mediated endocytosis
pathway.

Endosome-associated BMP transcriptional signaling
In order to evaluate the functional contribution of these MxA endosomes on transcriptional
signaling by BMP4/9 we first optimized a BMP-responsive-luciferase reporter construct (BREluc) known to respond to pSmad1/5/8 [30] for studies in endothelial cells and in 293T cells.
Representative experiments are illustrated in Fig 6A and 6C. Primary HPAECs and the endothelial cell line EA.hy926, while responsive to BMP4 and BMP9, proved difficult to transfect
replicably. In contrast the 293T cells showed a robust response to BMP4 and BMP9 (100200-fold). In light of the practical difficulties encountered in working with primary endothelial
cells (or even primary pulmonary arterial smooth muscle cells; not shown) in these transient
luciferase-reporter transfection experiments, and the observation that MxA endosomes were
also seen in 293T cells (Figs 3–5), we focused our effort on 293T cells in order to answer the
question whether MxA endosomes affected BMP4/9 signaling. In 293T cells, both BMP4 and
BMP9 showed transcription enhancing activity in the concentration range 1–2 ng/ml (Fig 6B
and 6D). Clear transcriptional stimulation was evident within 2 hr of the beginning of ligand
exposure and persisted for 12–16 hr (Fig 6E and 6F).
The contribution of membrane-associated endocytic pathways in mediating BMP4 and
BMP9-activated transcriptional signaling in the 293T cell-pBRE-luc reporter system used by
us was investigated using two different strategies: by evaluating the effects on signaling of
cotransfecting vectors expressing various endocytosis-mediator proteins, and by evaluating
effects of the endocytosis inhibitor dynasore. The data in Fig 7A and 7D show that this signaling was stimulated by overexpression of the clathrin heavy chain (CLT-HC), but markedly
inhibited by expression of wild-type (wt) caveolin-1 (cav-1). This inhibition by cav-1 expression was evident on both basal and BMP-inducible signaling even when a low concentration
of the expression construct was used in the transfection reaction (in the range from 0.03 ng to
0.3 ng per culture; not shown). Parenthetically, 293T cells do not express detectable endogenous cav-1 as assayed by Western blotting of cell extracts, and thus the exogenously expressed
cav-1 is the only pool of cav-1 present in these cells. The data summarized in Fig 7B and 7E
show that overexpression of the dominant negative (DN) forms of epsin 2a and dynamin 2
(the K44A mutant) inhibited BMP4 and BMP9 signaling. Additionally, Fig 7C and 7F show
that the endocytosis inhibitor dynasore reduced transcriptional signaling elicited by either
BMP4 or BMP9. Taken together these data are evidence of the involvement of a clathrin-mediated endocytosis pathway in productive transcriptional signaling by BMP4 and BMP9 in the
293T cell-pBRE-luc system used by us, and a negative effect on signaling by cav-1. This dichotomy confirms previous observations about the regulation of TGF-β/Smad transcriptional signaling [18].
Thus, in light of (a) the strong BMP-stimulated inducibility of the pBRE-luc in 293T cells
(Fig 6), and (b) confirmation of the involvement of membrane-associated trafficking in productive BMP4/9 signaling in these cells (Fig 7), we selected this cell system for experiments to
investigate whether there might be any cross-talk between exogenously expressed MxA and
transcriptionally productive BMP signaling.
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Fig 5. MxA endosomes carry early endosome markers and RSmad1/5/8. Double-label
immunofluorescence imaging was carried out on MxA-vector transfected HEK293T cells for the indicated
protein markers of early endosomes (EEA1, CLT-LC, Rab5), the transcription factors RSmad1/5/8 and
caveolin-1-GFP and LAMP2 as indicated in Materials and Methods. Arrows indicate MxA-positive structures
also positive for the respective second antigen. Scale bar = 10 μm. Pearson’s R (with Costes’ automatic
thresholding) comparing MxA images with those of EEA1, CLT-LC, Rab5, RSmad1/5/8, LAMP2 and Cav1-GFP were respectively 0.879, 0.704, 0.908, 0.709, 0.277 and 0.211.
doi:10.1371/journal.pone.0166382.g005
PLOS ONE | DOI:10.1371/journal.pone.0166382 November 22, 2016
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Fig 6. Response of pBRE-Luc in different cells and to different BMP concentrations and duration of BMP exposure. Cultures of human kidney cell
line HEK293T (Panels A-a, C-a, B, D, E and F], human pulmonary arterial endothelial cells HPAEC (Panels A-b and C-b) or human umbilical vein
endothelial cells EA.hy926 (Panels A-c and C-c) were transiently transfected with reporter construct pBRE-Luc together with constitutive β-galactosidase
expression construct pCH110. 24 hr later the cultures were serum starved for 4 hr, followed by treatment with BMP4 or BMP9 for 15 hr at the indicated
concentrations (Panels A-D) or 10ng/ml for the indicated times (Panels E and F). Cell lysates were assayed for β-galactosidase and luciferase activities.
Within each experiment, the luciferase data were normalized for β-galactosidase activity in each extract. Each variable was investigated in single (A-b) or
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triplicate cultures (all other panels). Data are shown as mean ± SE. Asterisks indicate p<0.05 for the particular group when compared to the respective BMPfree groups.
doi:10.1371/journal.pone.0166382.g006

Fig 7. Effect of modifying the caveolin- or clathrin-mediated endocytic pathways on productive transcription following
of BMP4 or BMP9 signaling. HEK293T cultures were transiently transfected with reporter construct pBRE-Luc and constitutive
β-galactosidase expression construct pCH110 (Panels C and F) or additionally with the indicated expression constructs (Panels
A, B, D and E). 24 hr later the cultures were serum starved for 4 hr, followed by treatment BMP4 or BMP9 at 10 ng/ml for 15 hr as
indicated (Panels A, B, D and E) or with dynasore at the indicated concentrations together with BMP4 or BMP9 for 3 hr (Panels
C and F). Cell lysates were assayed for β-galactosidase and luciferase activities. Within each experiment, the luciferase data
were normalized for β-galactosidase activity in each extract. Each variable was investigated in triplicate. Data are shown as the
mean ratio of the normalized luciferase activities in response to 10 ng/ml BMP4/9 compared to that in the absence of BMPs
(“fold-inducibility”); error bars denote ± SE. Asterisks indicate p<0.05 for the particular group when compared to the control
groups in Panels A, B, D and E or to the dynasore-free groups in Panels C and F. Cav-1, caveolin-1; CLT-HC, clathrin heavy
chain.
doi:10.1371/journal.pone.0166382.g007
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IFN-α and MxA enhance basal and BMP4/9-inducible transcriptional
signaling
The question of whether IFN-α per se modulated Smad-dependent transcriptional signaling
was addressed in primary cultures of HPAECs under conditions that showed a marked induction of endogenous endosome-associated comparable to those in Figs 1 and 2. Fig 8A summarizes pooled data from two independent experiments in which HPAEC cultures were
transfected with the BRE-luc reporter using Lipofectamine 3000. There was an increase in the
BRE-Id1-luc reporter activity in cultures treated with IFN-α whether by itself or together with
BMP4. However, similar to the data summarized in Fig 6A, the magnitude of the BRE-luc
activity in HPAECs was lower than that which can be observed in 293T cells. However, in
293T cells which give a far greater BMP-inducible luciferase signal (Fig 6A), IFN-α induced
MxA only minimally, if at all ([29], and data not shown). Thus as a compromise, we investigated whether expression of MxA in 293T cells by itself using an exogenous expression vector
construct had a concentration-dependent enhancing effect on basal transcription of the BREluc reporter (Fig 8B). The data in Fig 8C show that expression of exogenous MxA in 293T cells
enhanced basal BRE-Id1-luciferase activity. Remarkably, exposure to BMP4 or BMP9 in the
presence of MxA caused an even further increase in levels of fold-inducibility of BRE-luc transcription (Fig 8D and 8E). We therefore used 293T cells for further mechanistic dissection of
the effects of MxA on BMP/Smad transcriptional signaling.

Enhancement by MxA of BMP4/9 signaling involves endocytosis and
microtubules
The involvement of endocytosis in the enhancement by MxA of BMP signaling was investigated using expression vectors of endocytosis regulatory proteins and the endocytosis inhibitor
dynasore. The data in Fig 9A, 9B and 9C show that the enhancing effect of MxA on BMP4-induced transcriptional signaling was inhibited by overexpression of the DN mutants of epsin2a
and dynamin 2, and by wt cav-1. In contrast increased expression of clathrin-HC did not affect
the MxA-produced enhanced signaling (Fig 9D). Furthermore, the data in Fig 10A and 10B
show that dynasore inhibited the enhancement of BMP4- and BMP9-induced signaling by
MxA. Moreover, Fig 10C shows that nocodazole, a microtubule inhibitor, reduced the effect of
MxA. In contrast, paclitaxel, a microtubule stabilizer, did not interfere with the enhancement
of inducible transcription by MxA (Fig 10D). These data indicate that the enhancement of
BMP-inducible signaling by MxA involved the clathrin-endocytic pathway and microtubules.
The increase in BMP-induced transcriptional output in MxA expressing cells (Fig 8C and
8D) was evident without commensurate BMP-induced increase in whole cell BMP-stimulated
pSmad1/5/8 levels (Fig 11A and 11B). However, following cell fractionation, an increase in the
ratio of nuclear pSmad1/5/8 to unphosphorylated Smad was evident even in these transient
transfection experiments (Fig 11C and 11D), suggesting a more efficient transit to the nucleus
in the presence of MxA.

Can MxA rescue the inhibition of transcriptional signaling by the F14,
KDF and R899X mutants of BMPR2?
The F14, KDF and R899X mutants of BMPR2 correspond to hereditary PAH-disease associated
autosomally-dominant mutants which are known to mislocalize in vascular cells and to inhibit
BMP-responsive signaling in 293T cells [1,2,3,31](details of the mutations and the subcellular
localization are in Materials and Methods, and in ref. [31]). We first confirmed that in our hands
in 293T cells that both basal and BMP-induced luciferase reporter activities were enhanced by
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Fig 8. IFN-α and MxA enhance basal and productive transcription in response to BMPs. Panel A:
HAPECs in 35 mm plates were transfected with the pBRE-luc reporter and the β-gal expression plasmids using
Lipofectamine 3000. The next day the cultures were either left untreated or exposed to IFN-α (3000 IU/ml) for
12 hrs. Cultures were then either continued as such (“Basal”) or exposed to BMP4 (30 ng/ml) for another 15 hr.
Graph summarizes pooled data from two independent experiments in terms of the BRE-Id1-luciferase/β-gal
activity normalized to the IFN-free groups (“CTR”) as 100%. Asterisks indicate p<0.05 comparing the IFNcontaining groups with the IFN-free groups. Panel B: Expression of MxA in HEK293T cultures transfected with
the MxA-HA expression vector. Whole-cell lysates were prepared 24 or 48 hr after transient transfection.
Immunoblots were carried out using equal aliquots protein (80 μg) from such extracts. Panels C-E: HEK293T
cultures were transiently transfected with reporter construct pBRE-Luc together with the constitutive β-
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glycosidase expression construct pCH110 and indicated amounts of the constitutive MxA-HA expression
construct. Twenty-four hr later the cultures were serum starved for 4 hr, followed by exposure to BMP4 or
BMP9 at 10 ng/ml for 15 hr (Panels D and E) or left untreated (Panel C) in triplicate for each variable. Cell
lysates were assayed for β-galactosidase and luciferase activities. Panel C shows the increase in basal
luciferase activity in response to MxA alone; Panels D and E show data for fold-inducibility (mean ± SE).
Asterisks indicate p<0.05 for the particular group when compared to the respective MxA-free groups in Panel
C, D and E.
doi:10.1371/journal.pone.0166382.g008

additional transfection with a wt BMPR2 construct (Fig 12A). Next we verified that expression
constructs corresponding to the F14, KDF and R899X mutants inhibited basal and BMP4-induced signaling (Fig 12B). We then evaluated whether MxA could overcome this inhibition.
The data in Fig 13A and 13B show again that MxA was able to enhance signaling in the
presence of wt BMPR2. Moreover, MxA also further enhanced BMP4 and BMP9 signaling in
control cells with endogenous BMPR2 alone (CTR groups in Fig 13D and 13E). Remarkably,
MxA enhanced basal signaling in the presence of the KDF and R899X mutants (Fig 13A and
13C), and partially rescued BMP4-induced signaling in the presence of the F14 and R899X
mutants (Fig 13B and 13D). Taken together, these data point to the ability of MxA to at least
partially rescue BMP signaling in the presence of some of the autosomally-dominant PAH-disease associated mutants of BMPR2.

Discussion
The present studies identify a previously unrecognized cellular function of MxA. This dynamin-family GTPase stimulates productive transcription activated by BMP4 and BMP9. We
determined that productive signaling initiated by both BMP4 and BMP9 transits along the clathrin-mediated endocytosis pathway in association with microtubules. Immunofluoresence
and immuno-electron microscopy showed the association of MxA with early endosomes, and
these, in turn, were often observed alongside microtubules [32,33] and ER tubules. The latter
organelles likely serve a scaffolding role in vectorial endosome trafficking as recently proposed
by Voeltz and colleagues [24]. In applying the Voeltz scaffolding model to the present data
(Fig 14), we propose that MxA (dimeric or oligomeric) might serve as a tether helping target
signaling endosomes to stay alongside microtubules and ER for purposes of vectorial transit
towards the nucleus. Numerous prior studies have emphasized the role of this vectorial transit
of “signaling endosomes” as contributing to the speed and efficiency of signal spread from the
plasma membrane to the vicinity of the nucleus [17,18,19,34,35,36].
There have been several reports in the literature between 2002 and 2015 in which investigators inferred that MxA associated with subcompartments of the smooth ER
[12,13,14,15,16,25,26,27,28]. Our data agree with the previously published images of variablysized punctate MxA-positive structures in the cytoplasm, but our conclusions disagree with
the previous inferences about ER localization. We note first of all that none of these prior studies dealt with the localization of IFN-α-induced endogenously expressed MxA (as in the present Fig 1). Second, even with respect to the localization of exogenously expressed MxA, we
note that the claim of an ER localizationof MxA derived from these prior studies is suspect in
that the prior investigators used syntaxin 17 (STX17) or autocrine motility factor receptor
(AMF-R) as purported markers of the ER, and not a structural protein of the smooth ER such
as reticulon-4 in their co-localization studies. Neither of STX17 nor AMF-R are considered
markers of the ER; STX17 is a marker of autophagosomes and shuttles among other cytoplasmic organelles [37,38], and AMF-R shuttles between the plasma membrane and intracellular organelles [15]. In contrast to these prior studies, we used the ER structural protein RTN4
as a marker in double-label co-localization studies and show that MxA endosomes, although

PLOS ONE | DOI:10.1371/journal.pone.0166382 November 22, 2016

14 / 27

MxA Stimulates Endosome-Associated Signaling by BMP4 and BMP9

Fig 9. Perturbation of the clathrin-mediated endocytic pathway and increased caveolin expression
abrogated the enhancing effect of MxA on transcriptional activation by BMP4. Panels A-D: HEK293T
cultures were transiently transfected with reporter construct pBRE-Luc together with constitutive βgalactosidase expression construct pCH110 with (solid columns) or without MxA (open columns) and the
indicated expression constructs. Twenty-four hr later the cultures were serum starved for 4 hr, followed by
treatment with BMP4 at 10 ng/ml for 15 hr or left untreated. Data are shown as fold-inducibility (mean ± SE).
Asterisk and pound signs indicate p<0.05 for the indicated group when compared to the–MxA control groups
or +MxA control groups, respectively. “NS” denotes for p>0.05 for the indicated groups.
doi:10.1371/journal.pone.0166382.g009

they lie alongside ER tubules, are distinct from the standard RTN4-based ER. Moreover, others
have also pointed to an endosomal association of MxA [17,39,40], as well as the presence of
MxA in cross-immunoprecipitable complexes with dynamin and amphiphysin II [39].
In the present studies of BMP4 and BMP9 signal transduction, we observed that disruption
of normal endocytosis resulted in inhibition of the transcriptional function of BMP signaling.
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Fig 10. Perturbation of the clathrin-mediated endocytic pathway and disruption of microtubules
dynamics abrogated the enhancing effect of MxA on transcriptional activation by BMP4. HEK293T
cultures were transiently transfected with reporter construct pBRE-Luc together with constitutive βgalactosidase expression construct pCH110 with (solid columns) or without MxA (open columns). 24 hr later
the cultures were serum starved for 4 hr and then pretreated with 15 μM dynasore (Panels A and B), 10 μg/ml
nocodazole (Panel C) or 20 nM paclitaxel (Panel D) at 37˚C for 30 min, followed by treatment with 0 or 10 ng/
ml BMP4 or BMP9 together with each chemical at 37˚C for another 3 hr (Panels A and B) or 15 hr (Panels C
and D). Cell lysates were assayed for β-galactosidase and luciferase activities. Within each experiment, the
luciferase data were normalized for β-galactosidase activity in each extract. Each variable was investigated in
triplicate. Data are shown as mean ± SE; as normalized luciferase activity in Panels A and B, and as foldinducibility in Panels C and D. Asterisk and pound signs indicate p<0.05 for the indicated group when
compared to the–MxA DMSO group or the +MxA DMSO groups, respectively.
doi:10.1371/journal.pone.0166382.g010

In these studies we used different genetic and chemical approaches to inhibit endocytosis, to
demonstrate the requirement for endocytosis in the transcriptional outcome of BMP4 and
BMP9 signaling. As with other cytokines, we observed that clathrin-mediated endocytosis was
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Fig 11. MxA expression does not affect whole-cell phospho-RSmad content but enhances the nuclear pRSmad/RSmad ratio in cells exposed
to BMP4 or BMP9. HEK293T cultures were transfected with pcDNA or MxA expression constructs (0.6 μg in Panels A and C, and the indicated amounts
in B). After 24 hr, cell cultures were left untreated or exposed to BMP4 or BMP9 at 10 ng/ml for 15 hr. Whole-cell extracts were prepared in the
experiments in Pansls A and B, while the cells were fractionated into a cytoplasmic and nuclear extract in Panel C using the hypotonic swelling method.
Immunoblotting assays were carried out using protein-matched aliquots (80 μg/lane in Panels A and B, and 50 μg/lane in Panel C) of the respective
extracts. Blots were probed for MxA and phospho-RSmad as indicated; β-actin and β-tubulin were used as internal loading control. Quantitation of the
blots shown in Panels A and B in terms of pRSmad activation normalized to β-actin (for Panel A) or β-tubulin (for Panel B) is shown in the graphs below
each respective blot. Panel D: Data illustrate the ratio of pRSmad/RSmad in the respective nuclear fractions (mean ± SE) calculated from experiment as
in Panel C. Asterisks indicate p<0.05 for the particular group compared to respective MxA-free group.
doi:10.1371/journal.pone.0166382.g011
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Fig 12. Effect of expression of wild-type (WT) and mutated BMPR2 species on productive
transcription in response to BMP4. HEK293T cultures were transiently transfected with reporter construct
pBRE-Luc together with constitutive β-galactosidase expression construct pCH110 and the indicated type
and amounts of WT (Panels A and B) or mutated (Panels B) BMPR2 expression constructs. Tweinty-four hr
later the cultures were serum starved for 4 hr, followed by treatment with BMP4 at 10 ng/ml (+BMP4) for 15 hr.
Cell lysates from uninduced (“basal”) or induced (“+BMP4”) cultures were assayed for β-galactosidase and
luciferase activities; each variable was evaluated in triplicate in panel B. Within each experiment, the
luciferase data were normalized for β-galactosidase activity in each extract. Data are shown as mean ± SE.
Asterisks indicate p<0.05 for the particular group when compared to the WT group.
doi:10.1371/journal.pone.0166382.g012

involved in productive transcriptional signaling, while caveolin-associated endocytosis was
inhibitory [18]. MxA was able to further stimulate signaling along the clathrin pathway but
unable to overcome the inhibition by caveolin-1. These data are in accord with observations of
a positive transcriptional outcome through signaling along the clathrin-endosome pathway
but a negative outcome by caveolin-1-endocytosis (the inhibitory effects of the caveolin pathway has been previously observed) [18,34,35,36]. The mechanisms that determine the sorting
balance between the clathrin- and caveolin endocytic pathways and their extent of cross-talk
under different physiological conditions (e.g. cell stress, nutrient starvation, and hypoxia)
remain to be explored.
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Fig 13. MxA partially rescues the inhibition of BMP4 signaling PAH-disease associated mutants of BMPR2 (F14,
KDF and R899X). HEK293T cultures were transiently transfected with reporter construct pBRE-Luc together with
constitutive β-galactosidase expression construct pCH110 with (solid columns) or without MxA (open columns) and the
indicated BMPR2 expression constructs (WT, F14, KDF and R899X). Twenty-four hr later the cultures were serum starved
for 4 hr followed by treatment with 0 (Panels A, C; “basal”) or 10 ng/ml BMP4 (Panels B, D) or BMP9 (Panel E) for 15 hr.
Cell lysates were assayed for β-galactosidase and luciferase activities. Within each experiment, the luciferase data were
normalized for β-galactosidase activity in each extract. Each variable was investigated in triplicate. Data are shown as
mean ± SE. Asterisks and pound signs indicate p<0.05 for the indicated group when compared to the–MxA control groups
or +MxA control groups, respectively.
doi:10.1371/journal.pone.0166382.g013

A subset of MxA-endosomes were located alongside ER tubules in both 293T cells and
endothelial cells. This spatial localization pattern of endosomes along the ER was similar to
that reported by the Voeltz group [22,24], implying the coupling between signaling endosomes
and ER tubules. We note that it has been already reported that MxA can bind microtubules
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Fig 14. MxA-signaling endosome model. Schematic shows the proposed scaffolding interactions between
MxA-endosomes, microtubules and ER that likely contribute to vectorial BMP signal transit through the
cytoplasm. CCP, clathrin coated pit; CCV, clathrin-coated vesicle.
doi:10.1371/journal.pone.0166382.g014

and the ER [26,32,33]. We suggest that MxA serves as a tether enabling signaling endosomes
(which are MxA-positive) to bind to microtubules and ER tubules as scaffolds during their
transit towards nucleus (Fig 14). Such a model would provide rapid and vectorially directed
transport from the plasma membrane to the nuclear pore region. As a member of dynamin
GTPase superfamily, MxA shares a highly conserved GTPase domain with dynamins which
are involved in the piching off of endocytic vesicles from the plasma membrane. Therefore, an
alternative mechanism for the enhancing effect of MxA on BMP4/9 signaling may include
enhancing the efficiency of membrane fission at the clathrin-coated pits to facilitate a more
rapid release of signaling endosomes into the cytoplasm contributing to enhanced BMP signaling (Fig 14).
The initial impetus to investigate the effect of MxA on BMP4 and BMP9 signaling were the
observations by George et al [10] that IFN-α contributed to hypoxic PAH in a mouse model,
and the converse observations by Bauer et al [11] that IFN-α was protective. In our experiments in HPAECs we observed that IFN-α enhanced basal and BMP4-stimulated BRE-Id1-luc
transcriptional activity, an observation consistent with a protective effect of IFN-α in PAH.
Moreover, the present observations that MxA expression enhanced signaling by BMP4 and
BMP9 are also aligned with a protective role of IFN-α. The IFN-α-induced protein MxA/Mx1
enhanced the vascular quiescence signaling of BMP4/9. These observations are also consistent
with the ability of MxA to partially rescue the inhibition of BMP signaling by PAH-diseaseassociated mutants of BMPR2 with different effects on different mutants. However, MxA is
only one of many hundreds of genes that are upregulated by IFN-α, and thus the observations
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that a small subset of patients given IFN-α develop PAH may reflect the actions of these myriad of other changes in IFN-treated vascular tissues in addition to upregulation of MxA.
To summarize, we demonstrate the association of MxA with early endosomes in HPAECs
and in 293T cells. These MxA endosomes stimulate the directionally vectorial transit of the
transcription activation signal generated by BMP4 and BMP9 at the plasma membrane along
the clathrin-mediated endocytic pathway. The present studies represent the first investigation
of cross-talk between MxA and BMP4/9 at the level of intracellular signal transit. Overall, the
data identify MxA as a novel candidate mechanism to consider by which Type I IFNs could
influence the pathogenesis of PAH and other vascular diseases.

Materials and Methods
Cells and cell culture
Human kidney cancer cell line HEK293T was obtained from the American Type Culture Collection (ATCC). These cells were grown in DMEM supplemented with 10% v/v fetal bovine
serum (FBS). HEK293T cells were seeded into 6-well, 24-well plates or 35mm-dishes coated
with fibronectin, collagen and bovine serum albumin (respectively 1 μg/ml, 30 μg/ml and
10 μg/ml in coating medium) [41,42,43]. Primary human pulmonary arterial endothelial cells
(HPAEC) were purchased from Clonetics (San Diego, CA). These were seeded into T-25, T-75
or 6-well plates coated with fibronectin, collagen and bovine serum albumin (respectively
1 μg/ml, 30 μg/ml and 10 μg/ml in coating medium) [41,42,43]. HPAECs were grown in
Medium 200 supplemented with low serum growth supplement LSGS (Cascade Biologics,
Carlsbad, CA) and were used between passages 4 and 10 [44]. The human endothelial cell line
EA.hy926 was a gift from Dr. Yang-Ming Yang (Dept. Cell Biology & Anatomy, New York
Medical College) and grown in DMEM supplemented with 10% v/v fetal bovine serum and
100 μM hypoxanthine, 0.4 μM aminopterin, and 16 μM thymidine [31]. Phase contrast
microscopy was carried out daily and at the conclusion of each experiment using a Nikon Diaphot Microscope and a Nikon Coolpix digital camera.

Growth factors, cytokines, and treatment
Recombinant human BMP4 (#314-BP) and BMP9 (#3209-BP) were purchased from R&D System (Minneapolis, MN). Recombinant human interferon-alpha 2a (IFN-α2a) was purchased
from BioVision (Milpitas, CA). Cell cultures were grown to confluence at 37˚C. For BMP
treatment cultures were washed twice with phosphate-buffered saline, replenished with
serum-free medium for 4–8 hr, and then exposed to the recombinant cytokine or growth factors indicated overnight (12–16 hr).

Plasmids and transient transfection experiments
The HA-tagged MxA expression vector (cloned into a pcDNA3 vector) was a gift from Dr.
Otto Haller (University of Freiburg, Germany). Caveolin-1 (GFP fused) expression vector was
from Dr. Jeffrey Pessin (SUNY Stony Brook). Clathrin heavy chain expression vector (CLTC)
(TC117104) (referred to as “CLT-HC” in this document) (cloned to pCMV6-XL5 vector) was
purchased from OriGene (Rockville, MD). Clathrin light chain expression vector (referred to
as “CLT-LC” or “CLC” in this document) was from Dr. Tomas Kirchhausen (Harvard Medical
School). Dynamin2-K44A expression vector was from Dr. Lois Greene (NHLBI). Epsin 2a
expression vector were from Dr. Richard Jove (University of South Florida). Constitutive
expression vectors for β-galactosidase (pCH110) and for Flag-tagged BMPR2 proteins [vectors
were 3xC-terminal Flag tag/CMV in pCIneo corresponding to wild-type (wt); “F14”—exon 3
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T354G (Cys118Trp), “KDF”—exon 8 C944T (Arg322X), and the 1x Flag-tagged BMPR2R899X protein were gifts from Dr. Yang-Ming Yang (Dept. of Cell Biology & Anatomy, New
York Medical College [31]. Plasmid transfections were carried out using PolyFect (Qiagen,
Valencia, CA) or Lipofectamine 3000 (for HPAECs; Invitrogen, Waltham, MA) and the
respective manufacturer’s protocols.

Construction of BMP reporter pBRE-Luc
The BMP reporter pBRE-Luc was constructed based upon the BMP-responsive Smad1/5/8
binding enhancer elements that regulate the human Id1 promoter [30]. Briefly, the synthetic
oligonucleotides 50 - CCGC G G C G C C AGC CTGACAGC CCGTCCTGGCG TCTAACG
GTCTGAC -30 (sense) and 50 - TCGAGTCAGAC CGTTAGA C GCCAGGACGGGCTGTCAG
GCT G G C G C CGCGGAGCT -30 (antisense), containing two CAGC sites (underlined), one
GGCGCC palindrome (highlight in grey), one GGCG site (subscript), two SBE (double underlined), SacI 50 -overlapping and XhoI 30 -overlapping on the sense strand and corresponding
antisense strand, were ligated and inserted into SacI and XhoI sites in pGL4.48 [luc2P/SBE/
Hygro] vector from Promega (Madison, WI) to substitute the original SBE fragment and generate the luciferase reporter construct with one copy of BRE fragment flanked by SacI and
XhoI (BREx1Luc). To generate a BRE luciferase reporter with two BRE fragments tandemly
linked, another copy of BRE fragment but franked by XhoI and BglII annealed from synthetic
oligonucleotides 50 - TCGAGCGC G G C G C C AGC CTGACAGC CCGTCCTGGCG TCTA
ACGGTCTGAA -30 and 50 - GATCTTCAGAC CGTTAGA C GCCAGGACGGGCTGTCAG
GCT G G C G C CGCGC -30 were inserted into BREx1Luc in XhoI and BglII sites. Thus we
generated a BRE luciferase reporter construct with two copies of BRE fragments tandemly
linked and flanked by SacI and BglII, called pBRE-Luc.

BRE-Luciferase reporter assays
Cultures (in 6- or 24-well plates or 35 mm plates) were transfected with pBRE-Luc, pCH110
and other plasmids indicated in different experiments, followed by treatment with respective
cytokines as described in individual experiments. Typically, 3 x 105 cells were plated in a 35
mm dish or in a well of a 6-well plate, and the cultures used for transfection the next day. Alternatively, 1.5 x 105 cells/well were plated in a 24-well plate and the cultures used for transfection
the next day. Each variable was typically evaluated in triplicate; each particular experiment
was independently replicated 2–4 times. At the conclusion of each experiment the cells were
harvested, lysed and the expression of luciferase assayed using the Luciferase Assay System
(E1500) purchased from Promega (Madison, WI) following the manufacturer’s instructions.
The lysate were also used to assay for expression of β-galactosidase activity by using chlorophenolred-β-D-galactopyranoside (CPRG) (10 884 308 001) purchased from Roche Diagnostics
(Indianapolis, IN) following a protocol provided by the manufacturer. Typically, luciferase
activity is expressed as mean activity per variable (n = 3 each) ± SE after normalization with
the β-galactosidase activity in the respective samples.

Cell extracts and Western blotting
Whole cell extracts, as well as cytoplasmic and nuclear extracts using hypotonic swelling and
Dounce breakage, were prepared from HEK293T cells as described previously [31,41,42] and
citations therein). Western blotting was carried out using 8, 10 or 12% SDS-polyacrylamide
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gels under reducing denaturing conditions as per procedures and protocols provided by Cell
Signaling Technology Inc. and ECL detection kit purchased from Thermo Scientific (34077)
(Rockford, IL) and Michigan Diagnostics (FWPD02-25) (Royal Oak, MI). Multiple exposures
of each blot were obtained to ensure that each of the signals was within the linear range. Western blot signals were quantitated using a Hoefer Scientific GS-300 scanning densitometer. Linear brightness and contrast adjustments of scanned images of blots were made using the NIH
Image J software. Images in blots were quantitated for optical density also using the NIH
Image J software.

Immunofluorescence imaging
Cultures were fixed using cold paraformaldehyde (4%) for 1 hr and then permeabilized using
a buffer containing digitonin (50 μg/ml)/sucrose (0.3M) [10,31,42,43] or 0.3% Triton X-100.
Immunofluorescence assays were carried out using antibodies from specific sources and corresponding to the specific catalog numbers indicated in parentheses below (dilution range
1:100 to 1:1000) as described earlier [41,42]. Respective immunofluorescence was imaged as
previously reported [42] using a Zeiss AxioImager M2 motorized microscopy system with
Zeiss W N-Achroplan 40X/NA0.75 or Zeiss EC Plan-Neofluor 100X/NA1.3 oil objectives
equipped with an high-resolution RGB HRc AxioCam camera and AxioVision 4.8.1 software
in a 1388 x 1040 pixel high speed color capture mode. Images in z-stacks were captured using
Zeiss AxioImager software; these stacks were then deconvolved and rendered in 3-D using
the 64-bit version of the Zeiss AxioVision software. Deconvolution of 2-D images was carried
out using Image J software. Controls included secondary antibodies alone, peptide competition assays and multiple different antibodies towards the same antigen. All data within each
experiment were collected at identical imaging settings. Colocalization analyses of structures
in regions of interest in double-label immunofluorescence images were carried out using
Costes’ automatic thresholding and the Pearson’s R correlation metric using the colocalization plugin in NIH Image J software (R = 1.0 represents complete overlap, R = 0.0 represents
no overlap; R  0.7 indicates strong colocalization).

Electron microscopy
For immuno-EM, the cultures were fixed with paraformaldehyde (4%) for 20 min at 37˚C, and
then another 40 min at room temperature [17,41,43]. After fixation, the cells were washed with
ice-cold phosphate-buffered saline (PBS), scraped into an Eppendorf tube and pelleted by centrifugation for 15 sec. The cell pellets were continued to be fixed in freshly made 2% paraformaldehyde in PBS containing 0.2% glutaraldehyde, pH 7.2–7.4 for 4 hours at 4˚C. After
washing with PBS, the cells were embedded with 10% gelatin, infused with sucrose, and cryosectioned at 80 nm thickness onto 200 mesh carbon-formvar coated copper grids. For single
MxA labeling, the grids were blocked with 1% coldwater fish skin gelatin (Sigma) for 5 min,
incubated with MxA antibody (rabbit pAb) in blocking solution for 2 hours at room temperature. Following washing with PBS, gold-conjugated secondary antibodies (15 nm Protein Agold, Cell Microscopy Center, University Medical Center Utrecht, 35584 CX Utrecht, The
Netherlands, or 18 nm Colloidal Gold-AffiniPure Goat Anti-Rabbit IgG, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) were applied for 1 hr. The grids were fixed in 1%
glutaraldehyde for 5 min, washed with distilled water, contrasted and embedded in a mixture
of 3% uranyl acetate and 2% methylcellulose in a ratio of 1 to 9. Stained grids were examined
using a Philips CM-12 electron microscope (FEI; Eindhoven, The Netherlands) and images
photographed with using a Gatan (4K x 2.7K) digital camera (Gatan, Inc., Pleasanton, CA).
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Antibody reagents
Mouse mAb to clathrin light chain (#12735), and to β-tubulin (#23949), rabbit pAbs to human
MxA (also referred to as human Mx1)(H-285)(#50509), to Flag/OctA (D-8) (#807), and to
Smad1/5/8 (N-18) (#6031) were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA). Rabbit Ab to pSmad1/5 (41D10)(#9516) was purchased from Cell Signaling Technology
(Beverly MA). Rabbit pAb to β-Actin (#A2066) was purchased from Sigma-Aldrich. Mouse
mAb to the HA tag (#26183) was from Thermo Fisher Scientific (Rockford, IL). Goat pAb to
RTN4/NogoB (N18) (#11027) was purchased from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA). Mouse mAbs to EEA1 (#610457), Rab5 (#610724), and LAMP2 (#555803) were
purchased from BD Biosciences (Eugene, OR).Respective AlexaFluor 488-, 594- or 645-tagged
secondary donkey antibodies to rabbit (#A-11008 and #A-11012), mouse (#A-21202 and
#A-21203) or goat (#A-11055 and #A-11058) IgG were from Invitrogen Molecular Probes
(Eugene, OR).

Chemical reagents
Dynamin GTPase inhibitor dynasore (#D7693), microtubule inhibitor nocodazole (#M1404)
and microtubule stabilizer paclitaxel (#T7402) were purchased from Sigma-Aldrich (St. Louis,
MO).

Statistical analyses
For luciferase reporter assays, the luciferase activity was presented as mean ± SE after normalization with the β-galactosidase activity among different samples. Statistical significance of such
data was evaluated using a two-tailed Student’s t-test in Microsoft Excel software in comparisons between two groups; ANOVA was used to evaluate significance in experiments with multiple groups.
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